View in EDS

Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.

Saved in:
Bibliographic Details
Title: Cell-cycle targeted cancer therapy: clinical advances, biological gaps, and the emergence of selective CDK4 inhibitors.
Authors: Safaroghli-Azar A; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Mekonnen LB; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Lenjisa J; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Milne R; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia., Wang S; Drug Discovery and Development, School of Pharmacy and Biomedical Science, College of Health, Adelaide University, Adelaide, 5001, SA, Australia. shudong.wang@adelaide.edu.au.
Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Apr 06; Vol. 19 (1). Date of Electronic Publication: 2026 Apr 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-8722
DOI:10.1186/s13045-026-01794-7